These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31409769)

  • 1. Targeting HIBCH to reprogram valine metabolism for the treatment of colorectal cancer.
    Shan Y; Gao Y; Jin W; Fan M; Wang Y; Gu Y; Shan C; Sun L; Li X; Yu B; Luo Q; Xu Q
    Cell Death Dis; 2019 Aug; 10(8):618. PubMed ID: 31409769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineating the neurological phenotype in children with defects in the ECHS1 or HIBCH gene.
    Marti-Sanchez L; Baide-Mairena H; Marcé-Grau A; Pons R; Skouma A; López-Laso E; Sigatullina M; Rizzo C; Semeraro M; Martinelli D; Carrozzo R; Dionisi-Vici C; González-Gutiérrez-Solana L; Correa-Vela M; Ortigoza-Escobar JD; Sánchez-Montañez Á; Vazquez É; Delgado I; Aguilera-Albesa S; Yoldi ME; Ribes A; Tort F; Pollini L; Galosi S; Leuzzi V; Tolve M; Pérez-Gay L; Aldamiz-Echevarría L; Del Toro M; Arranz A; Roelens F; Urreizti R; Artuch R; Macaya A; Pérez-Dueñas B
    J Inherit Metab Dis; 2021 Mar; 44(2):401-414. PubMed ID: 32677093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of mitochondrial aconitase promotes colorectal cancer progression via SCD1-mediated lipid remodeling.
    You X; Tian J; Zhang H; Guo Y; Yang J; Zhu C; Song M; Wang P; Liu Z; Cancilla J; Lu W; Glorieux C; Wen S; Du H; Huang P; Hu Y
    Mol Metab; 2021 Jun; 48():101203. PubMed ID: 33676027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECHS1 mutations in Leigh disease: a new inborn error of metabolism affecting valine metabolism.
    Peters H; Buck N; Wanders R; Ruiter J; Waterham H; Koster J; Yaplito-Lee J; Ferdinandusse S; Pitt J
    Brain; 2014 Nov; 137(Pt 11):2903-8. PubMed ID: 25125611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite studies in HIBCH and ECHS1 defects: Implications for screening.
    Peters H; Ferdinandusse S; Ruiter JP; Wanders RJ; Boneh A; Pitt J
    Mol Genet Metab; 2015 Aug; 115(4):168-73. PubMed ID: 26163321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA.
    Wang S; Xiao Z; Hong Z; Jiao H; Zhu S; Zhao Y; Bi J; Qiu J; Zhang D; Yan J; Zhang L; Huang C; Li T; Liang L; Liao W; Ye Y; Ding Y
    Cancer Lett; 2018 Dec; 439():78-90. PubMed ID: 30253191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.
    Yang H; Higgins B; Kolinsky K; Packman K; Bradley WD; Lee RJ; Schostack K; Simcox ME; Kopetz S; Heimbrook D; Lestini B; Bollag G; Su F
    Cancer Res; 2012 Feb; 72(3):779-89. PubMed ID: 22180495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIBCH deficiency in a patient with phenotypic characteristics of mitochondrial disorders.
    Reuter MS; Sass JO; Leis T; Köhler J; Mayr JA; Feichtinger RG; Rauh M; Schanze I; Bähr L; Trollmann R; Uebe S; Ekici AB; Reis A
    Am J Med Genet A; 2014 Dec; 164A(12):3162-9. PubMed ID: 25251209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
    Wang J; Zhao X; Jin L; Wu G; Yang Y
    Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model.
    Iwai T; Sugimoto M; Harada S; Yorozu K; Kurasawa M; Yamamoto K
    Oncol Rep; 2016 Aug; 36(2):626-32. PubMed ID: 27350037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A therapeutic regimen for 3-hydroxyisobutyryl-CoA hydrolase deficiency with exercise-induced dystonia.
    Xu Y; Zhang J; Yu K; Feng F; Sun X; Li C; Li H; Cui L
    Eur J Paediatr Neurol; 2019 Sep; 23(5):755-759. PubMed ID: 31679561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
    Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
    Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
    Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
    Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
    Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
    Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decyl caffeic acid inhibits the proliferation of colorectal cancer cells in an autophagy-dependent manner in vitro and in vivo.
    Chen C; Kuo YH; Lin CC; Chao CY; Pai MH; Chiang EI; Tang FY
    PLoS One; 2020; 15(5):e0232832. PubMed ID: 32401800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Common Polymorphism in HIBCH Influences Methylmalonic Acid Concentrations in Blood Independently of Cobalamin.
    Molloy AM; Pangilinan F; Mills JL; Shane B; O'Neill MB; McGaughey DM; Velkova A; Abaan HO; Ueland PM; McNulty H; Ward M; Strain JJ; Cunningham C; Casey M; Cropp CD; Kim Y; Bailey-Wilson JE; Wilson AF; Brody LC
    Am J Hum Genet; 2016 May; 98(5):869-882. PubMed ID: 27132595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Movement disorders in valine métabolism diseases caused by HIBCH and ECHS1 deficiencies.
    François-Heude MC; Lebigot E; Roze E; Warde MTA; Cances C; Damaj L; Espil C; Fluss J; de Lonlay P; Kern I; Lenaers G; Munnich A; Meyer P; Spitz MA; Torre S; Doummar D; Touati G; Leboucq N; Roubertie A
    Eur J Neurol; 2022 Nov; 29(11):3229-3242. PubMed ID: 36200804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
    Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of oxidative phosphorylation and IDH2 sensitizes colorectal cancer to a naphthalimide derivative and mitoxantrone.
    Ge C; Wang Y; Feng Y; Wang S; Zhang K; Xu X; Zhang Z; Zhao Y; Wang Y; Gao L; Dai F; Xie S; Wang C
    Cancer Lett; 2021 Oct; 519():30-45. PubMed ID: 34166768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.